Full Library

Return to list of results

Herpesvirus Infections Potentiated by Biologics

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Journal Article
Authors/contributors
Title
Herpesvirus Infections Potentiated by Biologics
Abstract
Herpesviruses such as herpes simplex virus (HSV) type 1 and 2, varicella-zoster virus (VZV), and cytomegalovirus (CMV) maintain lifelong latency in the host after primary infection and can reactivate periodically either as asymptomatic viral shedding or as clinical disease. Immunosuppression, including biologic therapy, may increase frequency and severity of herpesvirus reactivation and infection. Licensed biologics are reviewed regarding their risks of potentiating HSV, VZV, and CMV reactivation and infection. Approaches to prophylaxis against HSV, VZV, and CMV infection or reactivation are discussed.
Publication
Infectious Disease Clinics
Date
2020/06/01
Volume
34
Issue
2
Pages
311-339
Journal Abbr
Infectious Disease Clinics
DOI
10.1016/j.idc.2020.02.006
URL
https://www.id.theclinics.com/article/S0891-5520(20)30008-8/abstract
Accessed
9/1/21, 3:44 PM
ISSN
0891-5520, 1557-9824
Language
English
Library Catalog
www.id.theclinics.com
Extra
Publisher: Elsevier PMID: 32444012
Citation
Ho, D. Y., Enriquez, K., & Multani, A. (2020). Herpesvirus Infections Potentiated by Biologics. Infectious Disease Clinics, 34(2), 311–339. https://doi.org/10.1016/j.idc.2020.02.006
ORGANISMS
HEME-ONC AND CELLULAR THERAPIES
Link to this record
https://transplantid.net/6VN7KYIW